ScinoPharm Taiwan Ltd (1789) — Cash Flow Quality Index
ScinoPharm Taiwan Ltd (1789) has a Cash Flow Quality Index of 12.07x as of March 2026. Operating cash flow of NT$199.47 Million exceeds net income of NT$16.53 Million, indicating high earnings quality where cash backs reported profits. Explore how well can ScinoPharm Taiwan Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ScinoPharm Taiwan Ltd Cash Flow Quality Index (2007–2025)
Historical Cash Flow Quality Index for ScinoPharm Taiwan Ltd across 19 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does ScinoPharm Taiwan Ltd generate cash.
Annual Cash Flow Quality Index for ScinoPharm Taiwan Ltd (2007–2025)
Year-by-year earnings quality comparison for ScinoPharm Taiwan Ltd.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 4.36x | NT$597.11 Million | NT$136.95 Million | ▲ +139.8% |
| 2024 | 1.82x | NT$750.91 Million | NT$413.02 Million | ▲ +174.4% |
| 2023 | 0.66x | NT$231.13 Million | NT$348.84 Million | ▼ -62.5% |
| 2022 | 1.77x | NT$773.79 Million | NT$437.96 Million | ▲ +4.8% |
| 2021 | 1.69x | NT$509.82 Million | NT$302.29 Million | ▼ -36.1% |
| 2020 | 2.64x | NT$946.31 Million | NT$358.50 Million | ▼ -11.3% |
| 2019 | 2.98x | NT$788.95 Million | NT$265.05 Million | ▲ +18.6% |
| 2018 | 2.51x | NT$1.23 Billion | NT$490.54 Million | ▲ +22.8% |
| 2017 | 2.04x | NT$971.71 Million | NT$475.30 Million | ▼ -0.5% |
| 2016 | 2.05x | NT$1.67 Billion | NT$810.60 Million | ▲ +57.9% |
| 2015 | 1.30x | NT$1.04 Billion | NT$802.88 Million | ▼ -11.8% |
| 2014 | 1.48x | NT$888.29 Million | NT$602.21 Million | ▲ +121.1% |
| 2013 | 0.67x | NT$939.47 Million | NT$1.41 Billion | ▼ -6.8% |
| 2012 | 0.72x | NT$981.55 Million | NT$1.37 Billion | ▼ -46.9% |
| 2011 | 1.35x | NT$1.29 Billion | NT$961.32 Million | ▼ -10.5% |
| 2010 | 1.50x | NT$1.56 Billion | NT$1.04 Billion | ▲ +20.5% |
| 2009 | 1.25x | NT$1.30 Billion | NT$1.04 Billion | ▼ -22.6% |
| 2008 | 1.61x | NT$1.41 Billion | NT$872.11 Million | ▲ +96.2% |
| 2007 | 0.82x | NT$504.50 Million | NT$613.27 Million | — |